AthemBio develops breakthrough technologies and transform them into solutions to solve major bioprocessing challenges.
AthemBio has raised $5K in total funding. The most recent round was Grant. The last funding was announced in August 2022.
AthemBio's investors include National Science Foundation, First Flight Venture Center.
AthemBio is headquartered in Durham, United States.
AthemBio develops breakthrough technologies and transform them into solutions to solve major bioprocessing challenges.
AthemBio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AthemBio — Funding & Investors." VCBacked, August 10, 2022, https://www.vcbacked.co/company/athembio. Accessed August 14, 2026.
VCBacked. (2022). AthemBio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/athembio
{{cite web |title=AthemBio — Funding & Investors |url=https://www.vcbacked.co/company/athembio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated